Clinical Trial Update: Semaglutide Treatment in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating semaglutide for obesity management in Type 1 diabetes, with the study listed as not yet recruiting and sponsored by No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Nordsjaellands Hospital | Conditions: Obesity in Diabetes, Obesity/Therapy | Phase 3 | Status: NOT_YET_RECRUITING